- Home
- NBTX vs GES Comparison
NBTX vs GES Comparison
Compare NBTX & GES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NBTX | GES |
|---|---|---|
| Founded | 2003 | 1981 |
| Country | France | Switzerland |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Apparel |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 872.4M |
| IPO Year | 2020 | 1996 |
Fundamental Metrics
Financial Performance| Metric | NBTX | GES |
|---|---|---|
| Price | $20.30 | $16.77 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 5 |
| Target Price | $8.00 | ★ $19.88 |
| AVG Volume (30 Days) | 34.1K | ★ 326.8K |
| Earning Date | 09-30-2025 | 11-25-2025 |
| Dividend Yield | N/A | ★ 5.36% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.07 |
| Revenue | $11,930,711.00 | ★ $3,144,417,000.00 |
| Revenue This Year | N/A | $8.97 |
| Revenue Next Year | $145.24 | $4.07 |
| P/E Ratio | ★ N/A | $15.66 |
| Revenue Growth | N/A | ★ 6.44 |
| 52 Week Low | $2.82 | $8.48 |
| 52 Week High | $30.35 | $17.15 |
Technical Indicators
Market Signals| Indicator | NBTX | GES |
|---|---|---|
| Relative Strength Index (RSI) | 42.02 | 43.29 |
| Support Level | $21.67 | $16.74 |
| Resistance Level | $23.40 | $16.79 |
| Average True Range (ATR) | 0.98 | 0.04 |
| MACD | -0.27 | 0.00 |
| Stochastic Oscillator | 11.22 | 29.17 |
Price Performance
Historical ComparisonAbout NBTX Nanobiotix S.A.
Nanobiotix SA is a clinical-stage biotechnology company that has one operating segment, which focuses on developing product candidates that use its proprietary nanotechnology to transform cancer treatment by increasing the efficacy of radiotherapy. The company develops NanoXray products to help patients receiving radiotherapy by magnifying the effect of radiotherapy within tumor cells without increasing the dose to surrounding healthy tissues. Its product candidate is NBTXR3, a preclinical research program for cancer immunotherapies.
About GES Guess? Inc.
Guess? Inc designs, markets distributes, and licenses contemporary apparel and accessories that reflect European fashion sensibilities and American Lifestyle under brands including Guess, Marciano, and G by Guess. The company has five reportable segments: Americas Retail, Americas Wholesale, Europe, Asia, and licensing. Geographically, the company derives maximum revenue from the United States.